Overall, existing data in animal models suggest that maintenance in the balance of ROS is critical

to successful microvascular aging. The limited work that has been performed to investigate the role of ROS in human microvascular aging is also discussed, and the need for future investigations of ROS signaling in older humans is considered. Healthy aging, from the microvascular standpoint, is associated with endothelial health and redox balance [23,74]. A decline in the function of the endothelium occurs with advancing age. This decline of function manifests as reduced angiogenic capacity, alteration of expression of adhesion molecules that regulate interaction with circulating factors and cells www.selleckchem.com/products/bmn-673.html of the immune system, and see more impaired vasodilatory function. The well-documented loss of endothelium-dependent vasodilation that occurs with advancing age is present

in both conduit arteries and resistance arterioles. Animal models have been used to characterize this loss of endothelium-dependent vasodilation and to define the mechanisms that underlie it. The preponderance of data obtained in animal models indicate that age-related endothelial dysfunction of the microcirculation occurs due to decreased availability of NO• [15,60,84,89]. Vasodilatory responses that are inhibited by NOS blockade have been reported to decline with Monoiodotyrosine age in arterioles from coronary [14,41,42], skeletal muscle [60,84,91,96], cerebral [55], and mesenteric [87] vascular beds. In resistance arteries of skeletal muscle, age-related reduction of NO•-dependent vasodilation is accompanied by reduced expression of eNOS [96]. In contrast, NO•-mediated dilation of soleus muscle resistance arteries declines with

advancing age despite an increase in eNOS protein levels [84]. Thus, the age-related decline in bioavailability of NO• may be dependent upon numerous factors that regulate both its production and degradation. Parallel findings have been reported in studies of the human microcirculation, obtained indirectly through measures of flow-mediated vasodilation or more directly through study of the skin microcirculation [11,34,66]. The eNOS activity is regulated by availability of substrate and cofactors, by protein–protein interactions, and by coordinated phosphorylation and dephosphorylation [22,25,31]. In the absence of sufficient levels of the cofactor, tetrahydrobiopterin, uncoupled eNOS can produce O2•−. Degradation of NO• is heavily dependent upon the presence of cellular O2•−, a by-product of cellular respiration, which reacts readily with NO•, eliminating its vasodilatory action [82]. Increased production of superoxide ions has been reported to reduce NO• availability in coronary, skeletal muscle, and mesenteric arterioles of aged rats [14,20,56,87,92].